Nishadil
Signup Signin
Delhi | 25°C (windy)
Pharma's Unfolding Drama: 340B Clashes, Vaccine Progress, and Cancer Innovation

Pharma's Unfolding Drama: 340B Clashes, Vaccine Progress, and Cancer Innovation
The Great Pharma Race: GLP-1s, Billions, and the Battle for What's Next

The Great Pharma Race: GLP-1s, Billions, and the Battle for What's Next
A New Era for Research Funding: NIH Ditches Paylines for a More Holistic Approach

A New Era for Research Funding: NIH Ditches Paylines for a More Holistic Approach
A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance

A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance
A New Hope for Kidney Disease Patients? FDA Greenlights Voyxact, But Pricing Questions Linger

A New Hope for Kidney Disease Patients? FDA Greenlights Voyxact, But Pricing Questions Linger
Another Heartbreak in the Alzheimer's Fight: J&J's Posdinemab Stumbles

Another Heartbreak in the Alzheimer's Fight: J&J's Posdinemab Stumbles
The Unfolding Saga of GLP-1 Drugs: A Potential Game-Changer for Alzheimer's?

The Unfolding Saga of GLP-1 Drugs: A Potential Game-Changer for Alzheimer's?
A Tragic First: Alpha-Gal Syndrome, the Tick-Borne Meat Allergy, Claims a Life

A Tragic First: Alpha-Gal Syndrome, the Tick-Borne Meat Allergy, Claims a Life
Shifting Sands of Science: How a Trump-Era NIH Policy Reshaped Grant Funding

Shifting Sands of Science: How a Trump-Era NIH Policy Reshaped Grant Funding
When Leadership Takes the Reins: Unpacking the FDA's Unusual Priority Voucher Vote

When Leadership Takes the Reins: Unpacking the FDA's Unusual Priority Voucher Vote
The Evolving Landscape of Biotech Innovation and Investment

The Evolving Landscape of Biotech Innovation and Investment
The FDA's Golden Ticket: A Moral Maze in Drug Development

The FDA's Golden Ticket: A Moral Maze in Drug Development
The Human Face of AI: How Recursion Pharma and Najat Khan Are Redefining Drug Discovery

The Human Face of AI: How Recursion Pharma and Najat Khan Are Redefining Drug Discovery
The Unseen Hand: WuXi AppTec's Unstoppable Ascent Amidst Global Scrutiny

The Unseen Hand: WuXi AppTec's Unstoppable Ascent Amidst Global Scrutiny
The Siren Song of Scale: Why Big Pharma's Mega-Mergers So Often Fall Flat

The Siren Song of Scale: Why Big Pharma's Mega-Mergers So Often Fall Flat
Dragon's Roar in the Lab: How China's Biotech Ambitions Are Quietly Reshaping Global Pharma

Dragon's Roar in the Lab: How China's Biotech Ambitions Are Quietly Reshaping Global Pharma
The GLP-1 Gold Rush: Will Trump Rewrite the Rules for Eli Lilly and Novo Nordisk?

The GLP-1 Gold Rush: Will Trump Rewrite the Rules for Eli Lilly and Novo Nordisk?
The Art of the Barely-There: Is 'Shallowing' the New Frontier of Sexual Pleasure?

The Art of the Barely-There: Is 'Shallowing' the New Frontier of Sexual Pleasure?
The Billion-Dollar Beatdown: How Novo Nordisk Clinched Metsera in a High-Stakes Pharma Showdown

The Billion-Dollar Beatdown: How Novo Nordisk Clinched Metsera in a High-Stakes Pharma Showdown
The Weight of Expectation: FDA, Obesity Drugs, and the Uneasy Dance Between Speed and Safety

The Weight of Expectation: FDA, Obesity Drugs, and the Uneasy Dance Between Speed and Safety
That Old Familiar Story: Daylight Saving Time, Stuck in Congressional Limbo (Again!)

That Old Familiar Story: Daylight Saving Time, Stuck in Congressional Limbo (Again!)
A Whisper Becomes a Roar: Unpacking the Turmoil at FDA's Biologics Hub

A Whisper Becomes a Roar: Unpacking the Turmoil at FDA's Biologics Hub
The Unlikely Turnaround: How One Healthcare Innovator Mastered the Art of Cost Control

The Unlikely Turnaround: How One Healthcare Innovator Mastered the Art of Cost Control
The Great Weigh-In: Pharma's Fierce Battle for the Future of Obesity, and What Else Keeps Them Up at Night

The Great Weigh-In: Pharma's Fierce Battle for the Future of Obesity, and What Else Keeps Them Up at Night
The Great Biotech Reckoning: Moderna's Wild Ride from Pandemic Hero to Post-COVID Crossroads

The Great Biotech Reckoning: Moderna's Wild Ride from Pandemic Hero to Post-COVID Crossroads
Biotech's Pulse Check: AI Rises, a Cancer Test Stumbles, and a Rare Disease Shines

Biotech's Pulse Check: AI Rises, a Cancer Test Stumbles, and a Rare Disease Shines
The Great Biotech Reckoning: Can Washington and Beijing Find Common Ground (Or Just More Friction)?

The Great Biotech Reckoning: Can Washington and Beijing Find Common Ground (Or Just More Friction)?
The Ozempic Paradox: When a Brand's Triumph Threatens Its Very Name

The Ozempic Paradox: When a Brand's Triumph Threatens Its Very Name
The Shifting Pulse: Could Dr. Casey Means Reshape America's Health as Surgeon General?

The Shifting Pulse: Could Dr. Casey Means Reshape America's Health as Surgeon General?
The Pharmaceutical Whirlwind: From Weight Loss Wonders to Mind-Altering Medicines, A New Era Unfolds

The Pharmaceutical Whirlwind: From Weight Loss Wonders to Mind-Altering Medicines, A New Era Unfolds
The Biotech Beat: Unpacking a Week of Breakthroughs, Billions, and Big Bets

The Biotech Beat: Unpacking a Week of Breakthroughs, Billions, and Big Bets
Biotech's Pulse: Gene-Editing's Leap, Cancer's New Fights, and What's Stirring the Industry

Biotech's Pulse: Gene-Editing's Leap, Cancer's New Fights, and What's Stirring the Industry
The Tightening Grip on Discovery: Why Funding Breakthroughs Just Got a Whole Lot Harder

The Tightening Grip on Discovery: Why Funding Breakthroughs Just Got a Whole Lot Harder
The Biotech Gambit: Novartis Reportedly Eyes Avidity in a High-Stakes Acquisition

The Biotech Gambit: Novartis Reportedly Eyes Avidity in a High-Stakes Acquisition
The Wild Possibility of 'Butt-Breathing': When Lungs Fail, Could Nature Offer an Unlikely Solution?

The Wild Possibility of 'Butt-Breathing': When Lungs Fail, Could Nature Offer an Unlikely Solution?
The Great Weight Shift: Biotech's Quest for What's Next in Obesity Care

The Great Weight Shift: Biotech's Quest for What's Next in Obesity Care
The Shadow Returns: What Trump's Drug Pricing Encore Means for Your Medicine Cabinet

The Shadow Returns: What Trump's Drug Pricing Encore Means for Your Medicine Cabinet
The Rx Revolution: How Startups Are Rewriting the Rules of Drug Affordability

The Rx Revolution: How Startups Are Rewriting the Rules of Drug Affordability
Another Heartbreak in the Fight Against Dementia: Alector's Flagship Drug Fails Late-Stage Trial

Another Heartbreak in the Fight Against Dementia: Alector's Flagship Drug Fails Late-Stage Trial
The Addiction Tsunami: Dr. Stephen Taylor's Urgent Call to Action

The Addiction Tsunami: Dr. Stephen Taylor's Urgent Call to Action
Beyond Vaccines: Moderna Co-Founder Warns of Widespread Attacks on Science

Beyond Vaccines: Moderna Co-Founder Warns of Widespread Attacks on Science
Beyond COVID: mRNA Vaccines Unleash a New Weapon Against Cancer's Toughest Foes

Beyond COVID: mRNA Vaccines Unleash a New Weapon Against Cancer's Toughest Foes
FDA Unleashes Game-Changing Incentive: Priority Review Vouchers Set to Revolutionize Drug Development

FDA Unleashes Game-Changing Incentive: Priority Review Vouchers Set to Revolutionize Drug Development
Load more..